(Adds Outlook)
For the full-year, Abbott (ABT) has raised its earnings outlook.
Abbott now projects earnings per share of $3.25 - $3.40 for the full year, up from the previous outlook of $3.20 - $3.40. Excluding special items, earnings per share is now expected in the range of $4.55 - $4.70, up from $4.50 - $4.70, guided earlier.
On average, 24 analysts polled by Thomson-Reuters expect the company to report earnings of $4.59 per share for the year.
For the second quarter Abbott sees earnings per share in the range of $0.69 - $0.73. Excluding one-time items, earnings per share is expected between $1.08 and $1.12, The consensus estimate stands at $1.12.
For the first quarter, Abbott revealed earnings that decreased from last year.
The company's bottom line totaled $1.23 billion, or $0.70 per share. This compares with $1.32 billion, or $0.75 per share, in last year's first quarter.
Excluding items, Abbott Laboratories reported adjusted earnings of $1.73 billion or $0.98 per share for the period.
The company's revenue for the quarter rose 2.2% to $9.96 billion from $9.75 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings (Q1): $1.23 Bln. vs. $1.32 Bln. last year.-EPS (Q1): $0.70 vs. $0.75 last year.-Revenue (Q1): $9.96 Bln vs. $9.75 Bln last year.
-Guidance:Full year EPS guidance: $4.55 - $4.70
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.